[{"NetIncomeLoss_3_Q3_USD":9221000.0,"LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_0_Q3_USD":18767000.0,"NetCashProvidedByUsedInInvestingActivities_3_Q3_USD":-5717000.0,"StockIssuedDuringPeriodValueNewIssues_3_Q3_USD":32141000.0,"StockIssuedDuringPeriodValueNewIssues_1_Q3_USD":32141000.0,"WeightedAverageNumberOfSharesIssuedBasic_3_Q3_shares":57349000.0,"WeightedAverageNumberOfSharesIssuedBasic_1_Q3_shares":58865000.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearThree_0_Q3_USD":3010000.0,"AssetsCurrent_0_Q3_USD":116311000.0,"IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_3_Q3_shares":14000.0,"IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_1_Q3_shares":16000.0,"SellingGeneralAndAdministrativeExpense_3_Q3_USD":12009000.0,"SellingGeneralAndAdministrativeExpense_1_Q3_USD":4018000.0,"CostOfGoodsAndServicesSold_3_Q3_USD":47098000.0,"CostOfGoodsAndServicesSold_1_Q3_USD":15604000.0,"AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_3_Q3_shares":3650000.0,"AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_1_Q3_shares":2304000.0,"StockIssuedDuringPeriodValueStockOptionsExercised_3_Q3_USD":2179000.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearFour_0_Q3_USD":3086000.0,"LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_0_Q3_USD":10211000.0,"CommonStockParOrStatedValuePerShare_0_Q3_USD":0.001,"IncreaseDecreaseInOtherCurrentLiabilities_3_Q3_USD":-394000.0,"RepaymentsOfNotesPayable_3_Q3_USD":4379000.0,"ProceedsFromIssuanceOfCommonStock_3_Q3_USD":32141000.0,"RepaymentsOfLongTermCapitalLeaseObligations_3_Q3_USD":93000.0,"PreferredStockParOrStatedValuePerShare_0_Q3_USD":0.001,"ShareBasedCompensation_1_Q3_USD":999000.0,"ShareBasedCompensation_3_Q3_USD":2754000.0,"Assets_0_Q3_USD":168178000.0,"CommonStockSharesIssued_0_Q3_shares":60827000.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_0_Q3_USD":2995000.0,"StockIssuedDuringPeriodValueStockOptionsExercised_1_Q3_USD":1474000.0,"OperatingLeaseRightOfUseAsset_0_Q3_USD":19053000.0,"IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_3_Q3_USD":101000.0,"ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest_1_Q3_USD":2207000.0,"CommitmentsAndContingencies_0_Q3_USD":null,"EarningsPerShareBasic_3_Q3_USD":0.1,"EarningsPerShareBasic_1_Q3_USD":0.01,"WeightedAverageNumberOfDilutedSharesOutstanding_3_Q3_shares":58058000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_1_Q3_shares":60097000.0,"AccountsReceivableNetCurrent_0_Q3_USD":27113000.0,"PreferredStockDividendsIncomeStatementImpact_3_Q3_USD":3604000.0,"PreferredStockDividendsIncomeStatementImpact_1_Q3_USD":1442000.0,"CommonStockValue_0_Q3_USD":61000.0,"GainLossOnTerminationOfLease_3_Q3_USD":0.0,"GainLossOnTerminationOfLease_1_Q3_USD":0.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearFive_0_Q3_USD":3171000.0,"DepreciationDepletionAndAmortization_3_Q3_USD":2540000.0,"ContractWithCustomerAssetNet_0_Q3_USD":5545000.0,"CashAndCashEquivalentsPeriodIncreaseDecrease_3_Q3_USD":34632000.0,"IncreaseDecreaseInEmployeeRelatedLiabilities_3_Q3_USD":3481000.0,"NetCashProvidedByUsedInFinancingActivities_3_Q3_USD":27027000.0,"RestrictedCash_0_Q3_USD":350000.0,"InterestAndOtherIncome_1_Q3_USD":23000.0,"InterestAndOtherIncome_3_Q3_USD":66000.0,"DepreciationAndAmortization_1_Q3_USD":900000.0,"DepreciationAndAmortization_3_Q3_USD":2500000.0,"PreferredStockSharesOutstanding_0_Q3_shares":1648000.0,"OperatingLeaseLiability_0_Q3_USD":21567000.0,"ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest_3_Q3_USD":9221000.0,"Liabilities_0_Q3_USD":82808000.0,"CashAndCashEquivalentsAtCarryingValue_0_Q3_USD":70894000.0,"OtherAssetsNoncurrent_0_Q3_USD":302000.0,"IncreaseDecreaseInAccountsPayable_3_Q3_USD":-951000.0,"NetIncomeLossAvailableToCommonStockholdersBasic_1_Q3_USD":765000.0,"NetIncomeLossAvailableToCommonStockholdersBasic_3_Q3_USD":5617000.0,"IncreaseDecreaseInInventories_3_Q3_USD":1063000.0,"OperatingLeaseLiabilityNoncurrent_0_Q3_USD":20233000.0,"CommonStockSharesAuthorized_0_Q3_shares":150000000.0,"RevenueFromContractWithCustomerExcludingAssessedTax_3_Q3_USD":68262000.0,"RevenueFromContractWithCustomerExcludingAssessedTax_1_Q3_USD":21806000.0,"AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_0_Q3_USD":20181000.0,"AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_3_Q3_USD":2754000.0,"AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_1_Q3_USD":999000.0,"NetCashProvidedByUsedInOperatingActivities_3_Q3_USD":13322000.0,"WeightedAverageNumberOfSharesOutstandingBasic_3_Q3_shares":57349000.0,"WeightedAverageNumberOfSharesOutstandingBasic_1_Q3_shares":58865000.0,"GainLossOnDispositionOfAssets_3_Q3_USD":0.0,"LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_0_Q3_USD":749000.0,"LiabilitiesCurrent_0_Q3_USD":62575000.0,"AccountsPayableCurrent_0_Q3_USD":6855000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_0_Q3_USD":71244000.0,"IncreaseDecreaseInContractWithCustomerAsset_3_Q3_USD":2245000.0,"ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans_3_Q3_USD":423000.0,"PrepaidExpenseAndOtherAssetsCurrent_0_Q3_USD":813000.0,"ProceedsFromStockOptionsExercised_3_Q3_USD":2179000.0,"GrossProfit_3_Q3_USD":21164000.0,"GrossProfit_1_Q3_USD":6202000.0,"NetIncomeLoss_1_Q3_USD":2207000.0,"PropertyPlantAndEquipmentNet_0_Q3_USD":32162000.0,"CapitalExpendituresIncurredButNotYetPaid_3_Q3_USD":1880000.0,"PaymentsOfDividendsPreferredStockAndPreferenceStock_3_Q3_USD":3244000.0,"PreferredStockSharesIssued_0_Q3_shares":1648000.0,"OperatingLeasePayments_3_Q3_USD":2200000.0,"ContractWithCustomerLiabilityRevenueRecognized_1_Q3_USD":3500000.0,"StockIssuedDuringPeriodValueEmployeeStockPurchasePlan_1_Q3_USD":244000.0,"IncrementalCommonSharesAttributableToCallOptionsAndWarrants_1_Q3_shares":937000.0,"IncrementalCommonSharesAttributableToCallOptionsAndWarrants_3_Q3_shares":507000.0,"AdditionalPaidInCapital_0_Q3_USD":647157000.0,"ShortTermLeaseCost_1_Q3_USD":99000.0,"ShortTermLeaseCost_3_Q3_USD":289000.0,"OperatingLeaseWeightedAverageDiscountRatePercent_0_Q3_pure":0.074,"StockIssuedDuringPeriodValueEmployeeStockPurchasePlan_3_Q3_USD":423000.0,"ContractWithCustomerLiabilityRevenueRecognized_3_Q3_USD":26300000.0,"EarningsPerShareDiluted_1_Q3_USD":0.01,"EarningsPerShareDiluted_3_Q3_USD":0.1,"StockIssuedDuringPeriodValueRestrictedStockAwardGross_1_Q3_USD":null,"StockIssuedDuringPeriodValueRestrictedStockAwardGross_3_Q3_USD":null,"PreferredStockSharesAuthorized_0_Q3_shares":5000000.0,"EmployeeRelatedLiabilitiesCurrent_0_Q3_USD":6500000.0,"LiabilitiesAndStockholdersEquity_0_Q3_USD":168178000.0,"OperatingLeaseCost_1_Q3_USD":788000.0,"PropertyPlantAndEquipmentGross_0_Q3_USD":52343000.0,"OperatingLeaseCost_3_Q3_USD":2364000.0,"ContractWithCustomerLiabilityCurrent_0_Q3_USD":47707000.0,"InventoryNet_0_Q3_USD":11946000.0,"NotesPayableCurrent_0_Q3_USD":0.0,"OperatingIncomeLoss_1_Q3_USD":2184000.0,"OperatingIncomeLoss_3_Q3_USD":9155000.0,"ImpairmentOfLongLivedAssetsHeldForUse_3_Q3_USD":0.0,"PreferredStockValue_0_Q3_USD":2000.0,"LesseeOperatingLeaseLiabilityPaymentsDue_0_Q3_USD":31778000.0,"OperatingLeaseLiabilityCurrent_0_Q3_USD":1334000.0,"OperatingExpenses_1_Q3_USD":4018000.0,"CommonStockSharesOutstanding_0_Q3_shares":60827000.0,"IncreaseDecreaseInAccountsReceivable_3_Q3_USD":18507000.0,"DividendsPreferredStock_1_Q3_USD":1081000.0,"DividendsPreferredStock_3_Q3_USD":3244000.0,"LeaseCost_1_Q3_USD":999000.0,"LeaseCost_3_Q3_USD":3086000.0,"OperatingExpenses_3_Q3_USD":12009000.0,"RetainedEarningsAccumulatedDeficit_0_Q3_USD":-561850000.0,"IncrementalCommonSharesAttributableToEquityForwardAgreements_3_Q3_shares":188000.0,"VariableLeaseCost_1_Q3_USD":112000.0,"VariableLeaseCost_3_Q3_USD":433000.0,"PaymentsToAcquirePropertyPlantAndEquipment_3_Q3_USD":5717000.0,"StockholdersEquity_0_Q3_USD":85370000.0,"OtherLiabilitiesCurrent_0_Q3_USD":179000.0,"IncrementalCommonSharesAttributableToEquityForwardAgreements_1_Q3_shares":279000.0,"IncreaseDecreaseInContractWithCustomerLiability_3_Q3_USD":18587000.0,"Ticker":"CDMO","CIK":"704562","name":"AVID BIOSERVICES, INC.","OfficialName":"Avid Bioservices Inc. Common Stock","form":"10-Q","period":"20210131","fy":"2021.0","fp":"Q3","qtrs":"3","uom":"USD","footnote":"nan","Market Cap":"1130539049.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20210308"}]